SciELO - Scientific Electronic Library Online

vol.30 issue1Sebaceous gland carcinoma restricted to bulb conjunctiva23-G pars plana vitrectomy in the acute endophthalmitis after cataract surgery author indexsubject indexarticles search
Home Pagealphabetic serial listing  

Services on Demand




  • Have no cited articlesCited by SciELO

Related links

  • Have no similar articlesSimilars in SciELO


Revista Cubana de Oftalmología

Print version ISSN 0864-2176On-line version ISSN 1561-3070


RODRIGUEZ RODRIGUEZ, Violeta et al. Post-vitrectomy endophthalmitis caused by Pseudomona aeruginosa. Rev Cubana Oftalmol [online]. 2017, vol.30, n.1. ISSN 0864-2176.

This is the report about a male 22 years-old myopic patient who underwent a pars plana 23 G vitrectomy in one eye (valuable) due to regmatogen retinal detachment. Twenty four hours after the surgery, he presented with vision loss, pain, eye bulb inflammation and ocular adnexa. He went to the emergency service where it was decided to admitted him to the hospital for sample taking and application of intravitreal injection of vancomycin (1 mg/0,1 mL) and ceftazidime (2 mg/0,1 mL) which brought about clinical improvement. The microbiological test reported the presence of ceftazidime and ciprofloxacine-susceptible Pseudomona aeruginosa. The fundus oculi performed five days after vitrectomy allowed observing whitish deports in the silicon oil/retina interface, so it was decided to remove the oil by making mixed incisions of 23 and 20 g (infusion, endoilumination and extraction, respectively), washing the anterior chamber, the vitreal chamber, returning the silicon oil and a second dosage of ceftazidime, all of which caused favorable postoperative progress. One week later, he was discharged from the hospital with replaced retina and better corrected vision of 0.1.

Keywords : endophthalmitis; intravitreal injection; Pseudomona aeruginosa.

        · abstract in Spanish     · text in Spanish     · Spanish ( pdf )


Creative Commons License All the contents of this journal, except where otherwise noted, is licensed under a Creative Commons Attribution License